# The metabolic advantage of being young and male in obesity treatment outcomes in mice

**Authors:** Amanda S. Dirnberger, Elen Yanina Aguirre-Rodriguez, Elias Carlos Aguirre-Rodriguez, John O. Degraft Hanson, Yanping Sun, Dave Delima, Benjamin F. Bykov, Aneirson Francisco da Silva, Marko Kraljević, Fernando Augusto Silva Marins, Ana BF Emiliano

PMC · DOI: 10.1038/s44324-025-00065-2 · npj Metabolic Health and Disease · 2025-08-01

## TL;DR

Young male mice have better weight loss outcomes than older females due to improved fat tissue response and gene activity.

## Contribution

This study identifies age and sex as critical factors influencing weight loss outcomes through WAT transcriptomic plasticity in mice.

## Key findings

- Male sex and youth are linked to better WAT mobilization and improved weight loss outcomes.
- Aging impairs WAT transcriptomic plasticity and reduces the effectiveness of weight loss interventions.
- Weight loss is associated with gene expression changes in IL17, ACE2, lipolysis, and adipocyte differentiation pathways.

## Abstract

Although diversity in clinical trials is important to test the efficacy of a treatment, weight loss trials rarely account for age and sex. To highlight this deficiency, we set out to test whether age and sex affect WAT mobilization after weight loss surgery or intermittent fasting, in an obese mouse model. Here we show that male sex, youth, and WAT transcriptomic plasticity are characteristics associated with improved weight loss outcomes. Conversely, aging impairs WAT mobilization and transcriptomic plasticity. Greater surgical weight loss is associated with changes in the expression of genes relevant to the IL17 inflammatory signaling pathway, angiotensin converting enzyme 2 (ACE2) signaling, lipolysis, carbohydrate metabolism and adipocyte differentiation. In conclusion, female sex and older age appear to hinder molecular processes necessary for the reversal of WAT expansion. Future studies should examine the relevance of these findings to human obesity therapeutics.

## Linked entities

- **Genes:** ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Muc16 (mucin 16) [NCBI Gene 73732] {aka 1110008I14Rik, Ca125, Gm1480, Gm21044}, SLC10A2 (solute carrier family 10 member 2) [NCBI Gene 6555] {aka ASBT, IBAT, ISBT, NTCP2, PBAM, PBAM1}, Kcnd1 (potassium voltage-gated channel, Shal-related family, member 1) [NCBI Gene 16506] {aka 1110037K09Rik, Kca2-1, Kv4.1, Shal, Shal1, mShal1}, Hoxb9 (homeobox B9) [NCBI Gene 15417] {aka Hox-2.5}, KDM6A (lysine demethylase 6A) [NCBI Gene 7403] {aka KABUK2, UTX, bA386N14.2}, Hs3st3b1 (heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1) [NCBI Gene 54710] {aka 3-OST-3B, 3OST3B1, 3Ost3b, Hs3st3b, m3-OST-3B}, Mgam (maltase-glucoamylase) [NCBI Gene 232714] {aka 6030407P20Rik, MGA}, Alpl (alkaline phosphatase, liver/bone/kidney) [NCBI Gene 11647] {aka ALP, APTNAP, Akp-2, Akp2, TNAP, TNSALP}, Tmem236 (transmembrane protein 236) [NCBI Gene 625286] {aka 2010003H20Rik, Fam23a, Gm613}, KANK4 (KN motif and ankyrin repeat domains 4) [NCBI Gene 163782] {aka ANKRD38, dJ1078M7.1}, CA1 (carbonic anhydrase 1) [NCBI Gene 759] {aka CA-I, CAB, Car1, HEL-S-11}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Msln (mesothelin) [NCBI Gene 56047] {aka C-ERC, MPF}, Mep1b (meprin 1 beta) [NCBI Gene 17288] {aka Mep-1b}, Adam8 (a disintegrin and metallopeptidase domain 8) [NCBI Gene 11501] {aka ADAM 8, CD156, CD156a, E430039A18Rik, MS2}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, Hs3st3a1 (heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1) [NCBI Gene 15478] {aka 3Ost3a, Hs3st3a}, HDC (histidine decarboxylase) [NCBI Gene 3067], IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Slc4a5 (solute carrier family 4, sodium bicarbonate cotransporter, member 5) [NCBI Gene 232156] {aka C330006M16, C330016K18Rik}, OSR2 (odd-skipped related transciption factor 2) [NCBI Gene 116039], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tcf21 (transcription factor 21) [NCBI Gene 21412] {aka Pod-1, Pod1, bHLHa23, capsulin, epc, epicardin}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Pigr (polymeric immunoglobulin receptor) [NCBI Gene 18703], FAM13A (family with sequence similarity 13 member A) [NCBI Gene 10144] {aka ARHGAP48, FAM13A1}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, Cadm1 (cell adhesion molecule 1) [NCBI Gene 54725] {aka 2900073G06Rik, 3100001I08Rik, Bl2, Igsf4, Igsf4a, Necl2}, GUCA2B (guanylate cyclase activator 2B) [NCBI Gene 2981] {aka GCAP-II, UGN}, Gdf3 (growth differentiation factor 3) [NCBI Gene 14562] {aka Gdf-3, Vgr-2, Vgr2, ecat9}, Slc15a1 (solute carrier family 15 (oligopeptide transporter), member 1) [NCBI Gene 56643] {aka D630032F02, PECT1, PEPT1}, Myo1e (myosin IE) [NCBI Gene 71602] {aka 2310020N23Rik, 9130023P14Rik, myosin-1e, myr 3}, Rspo1 (R-spondin 1) [NCBI Gene 192199] {aka R-spondin, Rspondin}, AKR1B10 (aldo-keto reductase family 1 member B10) [NCBI Gene 57016] {aka AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS}, S100G (S100 calcium binding protein G) [NCBI Gene 795] {aka CABP, CABP1, CABP9K, CALB3}, Fmo13 (flavin containing monooxygenase 13) [NCBI Gene 226601] {aka EG226601, Gm4846}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, Ggt7 (gamma-glutamyltransferase 7) [NCBI Gene 207182] {aka 1110017C11Rik, 6330563L03Rik, Ggtl3}, Npc1l1 (NPC1 like intracellular cholesterol transporter 1) [NCBI Gene 237636] {aka 9130221N23Rik, Gm243}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, Ace2 (angiotensin converting enzyme 2) [NCBI Gene 70008] {aka 2010305L05Rik}, DDX3X (DEAD-box helicase 3 X-linked) [NCBI Gene 1654] {aka CAP-Rf, DBX, DDX14, DDX3, HLP2, MRX102}, Slc28a1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 1) [NCBI Gene 434203] {aka CNT 1, Cnt1}, Upk3b (uroplakin 3B) [NCBI Gene 100647] {aka P35, PMS2L14, UpIIIb}, Atp6v0a2 (ATPase, H+ transporting, lysosomal V0 subunit A2) [NCBI Gene 21871] {aka 8430408C20Rik, ATP6a2, Atp6n1d, Atp6n2, ISF, J6B7}, Slc2a2 (solute carrier family 2 (facilitated glucose transporter), member 2) [NCBI Gene 20526] {aka Glut-2, Glut2}, Slc5a11 (solute carrier family 5 (sodium/glucose cotransporter), member 11) [NCBI Gene 233836] {aka 2010013B02Rik, Kst1, RKST2, SMIT2, Slc5a10}, CREB3L3 (cAMP responsive element binding protein 3 like 3) [NCBI Gene 84699] {aka CREB-H, CREBH, HYST1481, HYTG2}, Myrf (myelin regulatory factor) [NCBI Gene 225908] {aka 6030439E18, Gm1804, Gm98, Mrf}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Wt1 (WT1 transcription factor) [NCBI Gene 22431] {aka D630046I19Rik, Wt-1}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}
- **Diseases:** SARS-CoV-2 infection (MESH:D000086382), Fat (MESH:D004620), fat mass (MESH:C536030), Gastric leaks (MESH:D013272), Weight Loss (MESH:D015431), diabetes (MESH:D003920), insulin resistance (MESH:D007333), DIO (MESH:D009765), visceral adiposity (MESH:D007418), overweight (MESH:D050177), inflammation (MESH:D007249), weight gain (MESH:D015430), cardiovascular and metabolic diseases (MESH:D002318), fibrosis (MESH:D005355), Sarcopenia (MESH:D055948), lean mass loss (MESH:D013851)
- **Chemicals:** Meloxicam (MESH:D000077239), histamine (MESH:D006632), water (MESH:D014867), Fat (MESH:D005223), fatty acid (MESH:D005227), lipid (MESH:D008055), carbohydrate (MESH:D002241), Glucose (MESH:D005947), cholesterol (MESH:D002784), Vicryl (MESH:D011098), CO2 (MESH:D002245), heparan sulfates (MESH:D006497), Enrofloxacin (MESH:D000077422), GLP-1RA (-), isoflurane (MESH:D007530), glycosaminoglycan (MESH:D006025), blood glucose (MESH:D001786), glutathione (MESH:D005978)
- **Species:** Gammacoronavirus (genus) [taxon 694013], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316924/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12316924/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12316924/full.md

---
Source: https://tomesphere.com/paper/PMC12316924